Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Edwards expands D.C. presence: Dirksen Lehman and Barry Liden are heading up Edwards Lifesciences' Washington, D.C., government affairs office, the firm announces Oct. 26. Lehman, the new VP-government affairs, joins Edwards from consulting firm Clark & Weinstock, where he led the health care practice. He previously served as special assistant to the President for legislative affairs as the White House's primary liaison to the Senate for health care issues (1"The Gray Sheet" Feb. 5, 2001, p. 24). Liden, director for government affairs, joined the firm in 2002. He previously was director of external communications and most recently directed the firm's state government affairs operations from the Irvine, Calif., headquarters. Edwards says the D.C. office will support the company's growing role in AdvaMed, of which CEO Michael Mussallem becomes chairman in 2008 (2"The Gray Sheet" March 12, 2007, In Brief)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel